BC3195 in Combination With Pembrolizumab in Participants With Locally Advanced or Metastatic Solid Tumors

NCT07469774 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

NOT_YET_RECRUITING

Status

111

Enrollment

INDUSTRY

Sponsor class

Conditions

Locally Advanced or Metastatic Solid Tumors

Interventions

DRUG: BC3195
DRUG: Pembrolizumab/KEYTRUDA®

Sponsor

Biocity Biopharmaceutics Co., Ltd.

Collaborators

[object Object]